Ligand Pharmaceuticals (LGND)
Ligand Pharmaceuticals Max Pain By Strike
LGND trades at $154.94, 10.7% above the near-term max pain of $140 expiring Sep 19, 2025 (30 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is falling across expirations ($95-$140), signaling increased put positioning or downside protection. High dispersion in max pain levels suggests competing forces and potential volatility.
Ligand Pharmaceuticals Max Pain By Expiry
Max pain for LGND shows a downward trend from 140 to 95, indicating bearish sentiment or hedging activity. The 36% spread signals divergent expectations across timeframes. Most levels below 154.94 may cap rallies. Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.
Max Pain Table
| Expiration Date | Max Pain | Max Pain vs Current Price |
|---|---|---|
| Sep 19, 2025 | 140 | -14.94 (-9.64%) |
| Oct 17, 2025 | 95 | -59.94 (-38.69%) |
| Nov 21, 2025 | 125 | -29.94 (-19.32%) |
| Feb 20, 2026 | 135 | -19.94 (-12.87%) |